source:[1] Exclusive: US FDA brass pushed internally for speedier Lilly weight-loss pill verdict - Reuters (https://www.reuters.com/sustainability/boards ...)[2] Absence of Bureaucracy at FDA Is Shooting Pharma in the Foot - BioSpace (https://www.biospace.com/policy/absence-of-bu ...)[3] FDA Approves USAntibiotics’ Augmentin XR in Historic First for Expedited Review Program - BioSpace (https://www.biospace.com/press-releases/fda-a ...)